ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 37 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $66,000 | +24.5% | 155,061 | +91.3% | 0.00% | 0.0% |
| Q4 2016 | $53,000 | -45.9% | 81,056 | +160.3% | 0.00% | 0.0% |
| Q3 2016 | $98,000 | -67.8% | 31,142 | -52.5% | 0.00% | -75.0% |
| Q4 2015 | $304,000 | -24.4% | 65,532 | -0.8% | 0.00% | -33.3% |
| Q3 2015 | $402,000 | +306.1% | 66,077 | +473.3% | 0.01% | +500.0% |
| Q2 2015 | $99,000 | +607.1% | 11,525 | +53.6% | 0.00% | – |
| Q3 2014 | $14,000 | -57.6% | 7,501 | -22.3% | 0.00% | -100.0% |
| Q2 2014 | $33,000 | +3200.0% | 9,650 | +3116.7% | 0.00% | – |
| Q1 2014 | $1,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,250,000 | $1,975,000 | 1.00% |
| Broadfin Capital, LLC | 3,567,624 | $5,636,000 | 0.24% |
| Abingworth LLP | 437,994 | $679,000 | 0.19% |
| GREAT POINT PARTNERS LLC | 250,000 | $395,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 400,000 | $632,000 | 0.18% |
| BVF INC/IL | 559,624 | $884,000 | 0.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $2,673,000 | 0.10% |
| Perceptive Advisors | 503,156 | $795,000 | 0.07% |
| Gruss Capital Management LP | 960,000 | $1,517,000 | 0.04% |
| Spark Investment Management LLC | 103,400 | $160,000 | 0.03% |